SEC 13F Intelligence

5am Venture Management, LLC / VRDN

5am Venture Management, LLC’s Viridian Therapeutics Inc Position

Does 5am Venture Management, LLC own Viridian Therapeutics Inc (VRDN)? Not currently — the last reported position was 736.6K shares worth $23M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$23M
Q4 2025
Shares
736.6K
% of Portfolio
+7.21%
Quarters Held
14
position exited

Position History VRDN

Reported value by quarter
Q3 ’22: $10MQ3 ’22Q4 ’22: $9MQ1 ’23: $7MQ1 ’23Q2 ’23: $7MQ3 ’23: $6MQ3 ’23Q4 ’23: $13MQ1 ’24: $13MQ1 ’24Q2 ’24: $10MQ3 ’24: $17MQ3 ’24Q4 ’24: $14MQ1 ’25: $10MQ1 ’25Q2 ’25: $10MQ3 ’25: $16MQ3 ’25Q4 ’25: $23Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 2025736.6K$23M+7.21%
Q3 2025736.6K$16M+5.82%
Q2 2025736.6K$10M+3.96%
Q1 2025736.6K$10M+3.76%
Q4 2024736.6K$14M+3.37%
Q3 2024736.6K$17M+3.46%
Q2 2024736.6K$10M+2.14%
Q1 2024736.6K$13M+2.89%
Q4 2023586.6K$13M+3.39%
Q3 2023410.0K$6M+1.81%
Q2 2023280.0K$7M+1.66%
Q1 2023280.0K$7M+1.82%
Q4 2022300.0K$9M+2.35%
Q3 2022484.9K$10M+1.91%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See 5am Venture Management, LLC’s full portfolio or all institutional holders of VRDN.